Pazolong Tablets (Pazopanib) – Uses, Strengths & Side Effects
Description
Pazolong Tablets contain pazopanib, an oral targeted anticancer medicine classified as a tyrosine kinase inhibitor (TKI). Pazopanib works by blocking certain proteins involved in tumour growth and the development of blood vessels that supply tumours.
Pazopanib is used under specialist medical supervision to treat specific cancers in adults. Patients and healthcare professionals searching for Pazolong Tablets in Singapore should verify the product's composition, manufacturer, approved indications and local registration status before considering its use.
Cordium Pharmaceuticals Pvt. Ltd. provides pharmaceutical product information to support informed enquiries from healthcare professionals, distributors and other authorised pharmaceutical-sector partners.
Pazolong Tablets Strengths
Pazopanib tablets are available in recognised strengths of 200 mg and 400 mg, depending on the specific product and market. However, the availability of these strengths under the Pazolong brand should be confirmed against the manufacturer's product documentation.
The appropriate dose depends on the patient's diagnosis, liver function, other medicines and treatment tolerance. Never select a strength or change a dose without consulting the treating oncologist.
Uses and Potential Benefits of Pazopanib
Pazopanib is prescribed for certain adult patients with:
Advanced renal cell carcinoma (RCC): A type of kidney cancer, including eligible patients receiving first-line treatment or treatment following previous cytokine therapy.
Selected advanced soft tissue sarcomas (STS): Particular subtypes of soft tissue cancer in patients who have previously received chemotherapy or whose disease has progressed after earlier treatment.
Pazopanib may help slow cancer progression in eligible patients by interfering with signalling pathways involved in tumour growth and blood vessel formation. Treatment outcomes vary, and the medicine is not suitable for every cancer type or patient.
A qualified oncologist must assess whether pazopanib is appropriate for an individual patient's condition.
Possible Side Effects of Pazolong Tablets
Like other targeted cancer medicines, pazopanib can cause side effects. Commonly reported effects include:
High blood pressure
Diarrhoea, nausea and vomiting
Reduced appetite
Tiredness and weakness
Changes in hair or skin colour
Abdominal discomfort
Increased risk of bleeding or bruising
Serious safety concerns include liver injury, severe bleeding, heart problems, blood clots and gastrointestinal perforation. Seek urgent medical attention for yellowing of the skin or eyes, severe abdominal pain, unusual bleeding, chest pain or difficulty breathing.
Patients require regular medical monitoring, including blood pressure checks and liver-function tests. Inform the treating doctor about all medicines, supplements, existing medical conditions and any planned surgery.
Important Safety Information
Pazopanib is a prescription-only cancer medicine and must be used under specialist supervision. It is generally taken on an empty stomach according to the prescribed instructions. Tablets should be swallowed whole rather than crushed or broken unless the applicable product information specifically directs otherwise.
Grapefruit and grapefruit juice may interact with pazopanib. Patients should also discuss pregnancy, breastfeeding and potential drug interactions with their healthcare professional.
In Singapore, check the Health Sciences Authority (HSA) and National Drug Formulary for current product registration and prescribing information before purchasing or supplying any pazopanib product.
Frequently Asked Questions (FAQs)
1. What is Pazolong used for?
Pazolong is described as a pazopanib product intended for targeted cancer treatment. Confirm the exact formulation and approved indications with the manufacturer and treating oncologist.
2. Is Pazolong available in Singapore?
Availability depends on the product's registration and authorised supply arrangements. Check the HSA or National Drug Formulary and consult a licensed healthcare provider.
3. What strengths are available?
Pazopanib products include 200 mg and 400 mg tablets in some markets. Confirm which strengths, if any, are available under the Pazolong brand.
4. Can Pazolong be taken without a prescription?
No. Pazopanib requires a prescription and specialist medical supervision.
5. Where can healthcare professionals enquire about Pazolong?
Healthcare professionals and authorised pharmaceutical-sector buyers may contact Cordium Pharmaceuticals Pvt. Ltd. to request product documentation, confirm available strengths and discuss applicable supply and regulatory requirements.
Contact Cordium Pharmaceuticals Pvt. Ltd.
For product-related enquiries, request verified product specifications, manufacturing information and applicable regulatory documentation directly from Cordium Pharmaceuticals Pvt. Ltd.







